From the beginning of the pandemic, HungaroTrial has been very active in COVID-19 clinical research. Our colleagues are dedicated to add our clinical development knowledge, medical expertise and research infrastructure to the global efforts to find safe and effective COVID-19 medications.
We are proud
to show that we have already started assisting in the fight with COVID-19, having submitted a Phase III application under the COVID-19 fast track application which received approval in 4 days.
Our Clinical Team is excited to be part of active research of possible COVID-19 therapies.
Explore how we lead our Sponsors to Success in COVID-19 clinical research
Phase II. COVID – 19 Infectology trial
HungaroTrial managed the clinical trial approval within less than 3 weeks for a COVID-19 phase II clinical trial in Romania. We enrolled a total of 65 subjects at 4 active sites.
The phase II study was successfully completed in Romania, and based on the positive results we’ve started to manage the phase IIb/III trial in Bosnia, Bulgaria, Serbia, North Macedonia, Croatia and Slovakia. Enrolment is already ongoing, with over 25% of the global enrolment target already completed, ahead of schedule.
COVID-19 medication study for a Korean Sponsor
HungaroTrial successfully managed a phase II./III. clinical trial for a Korean Sponsor researching a new COVID-19 medication. The trial was based in Serbia and Macedonia. HungaroTrial managed to enrol 103 patients in just 11 days, ensuring a timely completion of the study. HungaroTrial managed to
- secure fast track approvals in both countries
- ensure a quick start-up, including fast contract signature
- select excellent sites with proven enrolment potential
- conduct fast data base cleaning for interim analyses (85% of the study data were generated in 28 days and cleaned in less than 1 month).
Advance Your Program Today
HungaroTrial is ready to help you complete your clinical trial program on time and to the highest standards.
Clinical development / Phase I-IV. services
We provide exceptional study design, management, monitoring, and reporting expertise for our partners to support their confident decisions for successful clinical development. Our network in the medical community of the CEE Region and long-term KOL connections ensure optimal trial site selection and enrolment rates for our Clients.
Medical device trials and Colsultancy
HungaroTrial’s Expert Team is ready to assist medical device companies through all phases of product development by regulatory consultancy and clinical trial services, with special focus on MDD => MDR transition.
For over 20 years HungaroTrial has provided CRA sourcing services in most CEE countries. The best proof of our service’s quality is the long list of our repeat clients, including 7 of the TOP 10 global pharmaceutical companies.